792
Views
197
CrossRef citations to date
0
Altmetric
Articles

Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention

, ScD & , PhD, FACN
Pages 567S-587S | Received 13 Sep 2004, Published online: 18 Jun 2013

REFERENCES

  • USDA National Nutrient Database for Standard Reference, Release 16, Reports by Single Nutrients. USDA Nutrient Data Laboratory, Agricultural Research Service. http://www.nal.usda.gov/fnic/foodcomp/Data/SR16 Accessed November 21,2003 .
  • Gartner C, Stahl W, Sies H: Preferential increase in chylomicron levels of the xanthophylls lutein and zeaxanthin compared to beta-carotene in the human. Int J Vitam Nutr Res66 :119– 125,1996 .
  • van het Hof KH, Brouwer IA, West CE, Haddeman E, Steegers-Theunissen RPM, van Dusseldorp M, Weststrate JA, Eskes TKAB, Hautvast JGAJ: Bioavailability of lutein from vegetables is 5 times higher than that of β-carotene. Am J Clin Nutr70 :261– 268,1999 .
  • Castenmiller JJ, West CE, Linssen JP, van het Hof KH, Voragen AG: The food matrix of spinach is a limiting factor in determining the bioavailability of beta-carotene and to a lesser extent of lutein in humans. J Nutr129 :349– 355,1999 .
  • Chopra M, O’Neill ME, Keogh N, Wortley G, Southon S, Thurnham DI: Influence of increased fruit and vegetable intake on plasma and lipoprotein carotenoids and LDL oxidation in smokers and nonsmokers. Clin Chem46 :1818– 1829,2000 .
  • Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB: Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr70 :247– 251,1999 .
  • Ojima F, Sakamoto H, Ishiguro Y, Terao J: Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density lipoprotein. Free Rad Biol Med15 :377– 384,1993 .
  • Bone RA, Landrum JT, Tarsis SL: Preliminary identification of the human macular pigment. Vis Res25 :1531– 1535,1985 .
  • Bone RA, Landrum JT, Fernandez L, Tarsis SL: Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci29 :843– 849,1988 .
  • Handelman GJ, Dratz EA, Reay CC, van Kuijk FJGM: Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci29 :850– 855,1988 .
  • Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidal I, Wang W: Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res64 :211– 218,1997 .
  • Bone RA, Landrum JT, Hime GW, Cains A, Zamor J: Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci34 :2033– 2040,1993 .
  • Krinsky NI, Landrum JT, Bone RA: Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr23 :171– 201,2003 .
  • Bernstein PS, Balashov NA, Tsong ED, Rando RR: Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci38 :167– 175,1997 .
  • Yemelyanov AY, Katz NB, Bernstein PS: Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res72 :381– 392,2001 .
  • Yeum KJ, Taylor A, Tang G, Russell RM: Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest Ophthalmol Vis Sci36 :2756– 2761,1995 .
  • Hammond BR, Wooten BR, Snodderly DM: Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci74 :499– 504,1997 .
  • Berendschot TTJM, Broekmans WMR, Klopping-Ketelaars IAA, Kardinaal AFM, Van Poppel G, Van Norren D: Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmol120 :1732– 1737,2002 .
  • Junghans A, Sies H, Stahl W: Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys391 :160– 164,2001 .
  • Khachik F, Bernstein PS, Garland DL: Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci38 :1802– 1811,1997 .
  • Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB: Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res72 :215– 223,2001 .
  • Rapp LM, Maple SS, Choi JH: Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci41 :1200– 1209,2000 .
  • Thomson LR, Toyoda Y, Langner A, Delori FC, Garnett KM, Craft N, Nichols CR, Cheng KM, Dorey CK: Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci43 :3538– 3549,2002 .
  • Sundelin SP, Nilsson SE: Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med31 :217– 225,2001 .
  • Hammond Jr BR, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM: Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci38 :1795– 1801,1997 .
  • Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM: Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr71 :1555– 1562,2000 .
  • Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE: A one year study of the macular pigment: the effect of 140 days of lutein supplement. Exp Eye Res65 :57– 62,1997 .
  • Berendschot TTJM, Goldbohm RA, Klopping WAA, van de Kraats J, van Norel J, van Norren D: Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci41 :3322– 3326,2000 .
  • Bone RA, Landrum JT, Guerra LH, Ruiz CA: Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr133 :992– 998,2003 .
  • Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG: Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci42 :1873– 1881,2001 .
  • Hammond BR, Wooten BR, Snodderly DM: Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci39 :397– 406,1998 .
  • Curran-Celentano J, Hammond Jr BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB: Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr74 :796– 802,2001 .
  • Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM: Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res71 :239– 245,2000 .
  • Broekmans WMR, Berendschot TTJM, Klopping-Ketelaars IAA, de Vries AJ, Goldbohm RA, Tijburg LBM, Kardinaal AFM, van Poppel G: Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr76 :595– 603,2002 .
  • Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME: Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci42 :439– 446,2001 .
  • National Advisory Eye Council: Vision Research—A National Plan: 1999–2003. US Dept of Health and Human Services, National Eye Institute, National Institutes of Health. NIH Publication No. 98-4120, Bethesda, MD,1998 .
  • Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE: Macular pigment in donor eyes with and without AMD: a case control study. Invest Ophthalmol Vis Sci42 :235– 240,2001 .
  • Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W: Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmol109 :1780– 1787,2002 .
  • Eye Disease Case-Control Study Group: Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol111 :104– 109,1993 .
  • Ferris FL III, Fine SL, Hyman L: Age-related macular degeneration and blindness due to neovascular maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol102 :1649– 1642,1984 .
  • Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W, for the Eye Disease Case-Control Study Group: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. J Am Med Assoc272 :1413– 1420,1994 .
  • Gale CR, Hall NF, Phillips DIW, Martyn CN: Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci44 :2461– 2465,2003 .
  • Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, Wright JD: Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol153 :424– 432,2001 .
  • Snellen ELM, Verbeek ALM, Van den Hoogen GWP, Cruysberg JRM, Hoyng CB: Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand80 :368– 371,2002 .
  • Richter S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J: Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry75 :216– 230,2004 .
  • Schupp C, Olano-Martin E, Gerth C, Morrissey BM, Cross CE, Werner JS: Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients. Am J Clin Nutr79 :1045– 1052,2004 .
  • Mares-Perlman JA, Brady WE, Klein R, Klein BEK, Bowen P, Stacewicz-Sapuntzakis M, Palta M: Serum antioxidants and age-related macular degeneration in a population based case control study. Arch Ophthalmol113 :1518– 1523,1995 .
  • Mares-Perlman JA, Klein R, Klein BEK, Greger JL, Brady WE, Palta M, Ritter LL: Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol114 :991– 997,1996 .
  • VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta W: Associations between antioxidant and zinc intake and the 5 year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol148 :204– 214,1998 .
  • Sanders TAB, Haines AP, Wormald R, Wright LA, Obeid O: Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr57 :428– 433,1993 .
  • Simonelli F, Zarrilli F, Mazzeo S, Verde V, Romano N, Savoia M, Testa F, Vitale DF, Rinaldi M, Sacchetti L: Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clin Chim Acta320 :111– 115,2002 .
  • Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P: Dietary antioxidant intake and incidence of early age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology109 :2272– 2278,2002 .
  • Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE: Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol122 :883– 892,2004 .
  • Taylor A, Jacques PF, Epstein EM: Relations among aging, antioxidant status, and cataract. Am J Clin Nutr62 :1439S– 1447S,1995 .
  • Babizhayev MA: Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing. Biochim Biophys Acta1315 :87– 99,1996 .
  • Bhuyan KC, Bhuyan DK: Molecular mechanisms of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res3 :67– 81,1984 .
  • Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE: A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr70 :509– 516,1999 .
  • Jacques PF, Chylack Jr LT, Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC, Taylor A: Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol119 :1009– 1019,2001 .
  • Taylor A, Jacques PF, Chylack Jr LT, Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC: Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr75 :540– 549,2002 .
  • Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, Spiegelman D, Willett WC, Hankinson SE: A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr70 :517– 524,1999 .
  • Mares-Perlman JA, Brady WE, Klein BEK, Klein R, Haus GJ, Palta M, Ritter LL, Shoff SM: Diet and nuclear lens opacities. Am J Epidemiol141 :322– 334,1995 .
  • Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Greger JL: Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol149 :801– 809,1999 .
  • Lyle BJ, Mares-Perlman JA, Klein BEK, Klein R, Palta M, Bowen PE, Greger JL: Serum carotenoids and tocopherols and incidence of age-related nuclear cataract. Am J Clin Nutr69 :272– 277,1999 .
  • Mares-Perlman JA, Brady WE, Klein BEK, Klein R, Palta M, Bowen P, Stacewicz-Sapuntzakis M: Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest Ophthalmol Vis Sci36 :276– 288,1995 .
  • Olmedilla B, Granado F, Blanco I, Herrero C, Vaquero M, Millan I: Serum status of carotenoids and tocopherols in patients with age-related cataracts: a case-control study. J Nutr Health Aging6 :66– 68,2002 .
  • Gale CR, Hall NF, Phillips DIW, Martyn CN: Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology108 :1992– 1998,2001 .
  • Olmedilla B, Granado F, Blanco I, Vaquero M: Lutein but not α-tocopherol supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition19 :21– 24,2003 .
  • Gonzalez de Mejia EG, Loarca-Pina G, Ramos-Gomez M: Antimutagenicity of xanthophylls present in Aztec marigold (Tagetes erecta) against 1-nitroprene. Mutat Res389 :219– 226,1997 .
  • Gonzalez de Mejia EG, Ramos-Gomez M, Loarca-Pina G: Antimutagenic activity of natural xanthophylls against aflatoxin B1 in Salmonella typhimurium. Environ Mol Mutagen30 :346– 353,1997 .
  • Okai Y, Higashi-Okai K, Yano Y, Otani S: Identification of antimutagenic substances in an extract of edible red alga, Porphyra tenera (Asakusa-nori). Cancer Lett100 :235– 240,1996 .
  • Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV: Lifestyle and nutritional correlates of cytochrome CYP1A2 activity. Inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics7 :11– 19,1997 .
  • Narisawa T, Fukaura Y, Hasebe M, Ito M, Aizawa R, Murakoshi M, Uemura S, Khachik F, Nishino H: Inhibitory effects of natural carotenoids, alpha-carotene, beta-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett107 :137– 142,1996 .
  • Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, Tanaka Y, Osawa T, Uraji T, Murakoshi M, Nishino H, Tsuda H: Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis19 :81– 85,1998 .
  • Chew BP, Brown CM, Park JS, Mixter PF: Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res23 :3333– 3339,2003 .
  • Park JS, Chew BP, Wong TS: Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice. J Nutr128 :1650– 1656,1998 .
  • Kozuki Y, Miura Y, Yagasaki K: Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett151 :111– 115,2000 .
  • Sumantran VN, Zhang R, Lee DS, Wicha MS: Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev9 :257– 263,2000 .
  • Muller K, Carpenter KI, Challis IR, Skepper JN, Arends MJ: Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic Res36 :791– 802,2002 .
  • Zhang LX, Cooney RV, Bertram JS: Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis12 :2109– 2114,1991 .
  • Gross MD, Bishop TD, Belcher JD, Jacobs Jr DR: Induction of HL-60 cell differentiation by carotenoids. Nutr Cancer27 :169– 173,1997 .
  • Haegele AD, Gillette C, O’Neill C, Wolfe P, Heimendinger J, Sedlacek S, Thompson HJ: Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol Biomark Prev9 :421– 425,2000 .
  • Jyonouchi H, Zhang L, Gross MD, Tomita Y: Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer21 :47– 58,1994 .
  • Jyonouchi H, Sun S, Mizokami M, Gross MD: Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr Cancer26 :313– 324,1996 .
  • Park JS, Chew BP, Wong TS, Zhang JX, Magnuson NS: Dietary lutein but not astaxanthin or beta-carotene increases pim-1 gene expression in murine lymphocytes. Nutr Cancer33 :206– 212,1999 .
  • Chew BP, Wong MW, Wong TS: Effects of lutein from marigold extract on immunity and growth of mammary tumors in mice. Anticancer Res16 :3689– 3694,1996 .
  • Kim HW, Chew BP, Wong TS, Park JS, Weng BBC, Byrne KM, Hayek MG, Reinhart GA: Modulation of humoral and cell-mediated immune responses by dietary lutein in cats. Vet Immunol Immunopath73 :331– 341,2000 .
  • Kim HW, Chew BP, Wong TS, Park JS, Weng BBC, Byrne KM, Hayek MG, Reinhart GA: Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopath74 :315– 327,2000 .
  • Khachik F, Beecher GR, Smith Jr JC: Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem22 :236– 246,1995 .
  • Collins AR, Olmedilla B, Southon S, Granado F, Duthie SJ: Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis19 :2159– 2162,1998 .
  • Torbergsen AC, Collins AR: Recovery of human lymphocytes from oxidative DNA damage. The apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr39 :80– 85,2000 .
  • Astley SB, Elliott RM, Archer DB, Southon S: Increased cellular carotenoid levels reduce the persistence of DNA single-strand breaks after oxidative challenge. Nutr Cancer43 :202– 213,2002 .
  • Chew BP, Park JS: Carotenoid action on the immune response. J Nutr134 :257S– 261S,2004 .
  • Park JS, Chew BP, Wong TS: Dietary lutein absorption from marigold extract is rapid in BALB/c mice. J Nutr128 :1802– 1806,1998 .
  • Hughes DA, Wright AJA, Finglas PM, Polley ACJ, Bailey AL, Astley SB, Southon S: Effects of lycopene and lutein supplementation on the expression of functionally associated surface molecules on blood monocytes from healthy male nonsmokers. J Infect Dis182 :S11– S15,2000 .
  • Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, Manson JE, Hankinson SE, Willett WC: Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst91 :547– 556,1999 .
  • Cho E, Spiegelman D, Hunter DJ, Chen WY, Zhang SM, Colditz GA, Willett WC: Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev12 :713– 720,2003 .
  • Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T, Graham S: Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst88 :340– 348,1996 .
  • Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E: Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden. Cancer Causes Control12 :529– 537,2001 .
  • Ito Y, Gajalakshmi KC, Sasaki R, Suzuki K, Shanta V: A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. J Epidemiol9 :306– 314,1999 .
  • Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E: Serum carotenoids and breast cancer. Am J Epidemiol153 :1142– 1147,2001 .
  • Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson Jr HE: Relationships of serum carotenoids, retinol, a-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes and Control9 :89– 97,1998 .
  • Rock CL, Saxe GA, Ruffin MT, August DA, Schottenfeld D: Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr Cancer25 :281– 296,1996 .
  • Rutqvist LE: The significance of hormone receptors to predict the endocrine responsiveness of human breast cancer. Acta Oncol29 :371– 377,1990 .
  • Kim MK, Park YG, Gong G, Ahn SH: Breast cancer, serum antioxidant vitamins, and p53 protein overexpression. Nutr Cancer43 :159– 166,2002 .
  • Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, Comstock GW: Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev11 :451– 457,2002 .
  • Terry P, Jain M, Miller AB, Howe GR, Rohan TE: Dietary carotenoids and risk of breast cancer. Am J Clin Nutr76 :883– 888,2002 .
  • Nkondjock A, Ghadirian P: Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal, Canada. Am J Clin Nutr79 :857– 864,2004 .
  • Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, Curtin J, Brinton LA: Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer82 :315– 321,1999 .
  • Ronco A, De Stafani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, LeBorgne F: Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr Cancer35 :111– 119,1999 .
  • Jarvinen R, Knekt P, Seppanen R, Teppo L: Diet and breast cancer risk in a cohort of Finnish women. Cancer Lett114 :251– 253,1997 .
  • Zhang S, Tang G, Russell RM, Mayzel KA, Stampfer MJ, Willett WC, Hunter DJ: Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am J Clin Nutr66 :626– 632,1997 .
  • Yeum KJ, Ahn SH, de Paiva SAR, Lee-Kim YC, Krinsky NI, Russell RM: Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr128 :1920– 1926,1998 .
  • Czeczuga-Semeniuk E, Wolczynski S, Markewicz W: Preliminary identification of carotenoids in malignant and benign neoplasms of the breast and surrounding fatty tissue. Neoplasma50 :280– 286,2003 .
  • Duitsman PK, Barua AB, Becker B, Olson JA: Effects of epoxycarotenoids, β-carotene and retinoic acid on the differentiation and viability of the leukemic cell line NB4 in vitro. Int J Vitam Nutr Res69 :303– 308,1999 .
  • Barua AB, Olson JA: Xanthophyll epoxides, unlike β-carotene monoepoxides, are not detectibly absorbed by humans. J Nutr131 :3212– 3215,2001 .
  • Khachik F, Beecher GR, Goli MB, Lusby WR: Separation, identification, and quantification of carotenoids in fruits, vegetables, and human plasma by high-performance liquid chromatography. Pure Appl Chem63 :71– 80,1991 .
  • Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J, Albanes D: Dietary carotenoids, serum β-carotene, and retinol and risk of lung cancer in the Alpha-Tocopherol, Beta-Carotene cohort study. Am J Epidemiol156 :536– 547,2002 .
  • De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L: Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer34 :100– 110,1999 .
  • Le Marchand L, Hankin JH, Kolonel LN, Beecher GR, Wilkens LR, Zhao LP: Intake of specific carotenoids and lung cancer risk. Cancer Epidemiol Biomarkers Prev2 :183– 187,1993 .
  • Goodman GE, Schaffer S, Omenn GS, Chen C, King I: The association between lung and prostate cancer risk, and serum micronutrients: results and lessons from Beta-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev12 :518– 526,2003 .
  • Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ: The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev6 :907– 916,1997 .
  • Le Marchand L, Hankin JH, Bach F, Kolonel LN, Wilkens LR, Stacewicz-Sapuntzakis M, Bowen PE, Beecher GR, Laudon F, Baque P: An ecological study of diet and lung cancer in the South Pacific. Int J Cancer63 :18– 23,1995 .
  • Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E: Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr72 :990– 997,2000 .
  • Ziegler RG, Colavito EA, Hartge P, McAdams MJ, Schoenberg JB, Mason TJ, Fraumeni Jr JF: Importance of α-carotene, β-carotene, and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst88 :612– 615,1996 .
  • Voorrips LE, Goldbohm RA, Brants HA, van Poppel GA, Sturmans F, Hermus RJ, van den Brandt PA: A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev9 :357– 365,2000 .
  • Wright ME, Mayne ST, Swanson CA, Sinha R, Alavanja MC: Dietary carotenoids, vegetables, and lung cancer risk in women: the Missouri women’s health study (United States). Cancer Causes Control14 :85– 96,2003 .
  • Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC: Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev12 :890– 898,2003 .
  • Rohan TE, Jain M, Howe GR, Miller AB: A cohort study of dietary carotenoids and lung cancer risk in women (Canada). Cancer Causes Control13 :231– 237,2002 .
  • Knekt P, Jarvinen R, Teppo L, Aromaa A, Seppanen R: Role of various carotenoids in lung cancer prevention. J Natl Cancer Inst91 :182– 184,1999 .
  • Garcia-Closas R, Agudo A, Gonzalez CA, Riboli E: Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer32 :154– 158,1998 .
  • Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC: Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev10 :767– 773,2001 .
  • Ito Y, Wakai K, Suzuki K, Tamakoshi A, Seki N, Ando M, Nishino Y, Kondo T, Watanabe Y, Ozasa K, Ohno Y, JACC Study Group: Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci94 :57– 63,2003 .
  • Ratnasinghe D, Forman MR, Tangre JA, Qiao Y, Yao SX, Gunter EW, Barrett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR: Serum carotenoids are associated with increased lung cancer risk among alcohol drinkers, but not among non-drinkers in a cohort of tin miners. Alcohol Alcoholism35 :355– 360,2000 .
  • Slattery ML, Benson J, Curtin K, Ma K, Schaeffer D, Potte RJD: Carotenoids and colon cancer. Am J Clin Nutr71 :575– 582,2000 .
  • Levi F, Pasche C, Lucchini F, La Vecchia C: Selected micronutrients and colorectal cancer. A case-control study from the canton of Vaud, Switzerland. Eur J Cancer36 :2115– 2119,2000 .
  • Comstock GW, Helzlsouer KJ, Bush TL: Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr53 :260S– 264S,1991 .
  • McMillan DC, Sattar N, Talwar D, O’Reilly DSJ, McArdle CS: Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancer. Nutrition16 :425– 428,2000 .
  • Talwar D, Ha TKK, Scott HR, Cooney J, Fell GS, O’Reilly DS, Lean MEJ, McMillan DC: Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer. Am J Clin Nutr66 :1283– 1285,1997 .
  • Rumi Jr G, Szabo I, Vincze A, Matus Z, Toth G, Rumi G, Mozsik G: Decrease in serum levels of vitamin A and zeaxanthin in patients with colorectal polyp. Eur J Gastroenterol Hepatol11 :305– 308,1999 .
  • Muhlhofer A, Buhler-Ritter B, Frank J, Zoller WG, Merkle P, Bosse A, Heinrich F, Biesalski HK: Carotenoids are decreased in biopsies from colorectal adenomas. Clin Nutr22 :65– 70,2003 .
  • Nair S, Norkus EP, Hertan H, Pitchumoni CS: Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls. Am J Gastroenterol96 :3400– 3405,2001 .
  • Terry P, Jain M, Miller AB, Howe GR, Rohan TE: Dietary carotenoid intake and colorectal cancer risk. Nutr Cancer42 :167– 172,2002 .
  • Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, Teppo L: Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. Eur J Clin Nutr56 :615– 621,2002 .
  • Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, Sandler RS: Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev12 :747– 754,2003 .
  • Enger SM, Longnecker MP, Chen MJ, Harper JM, Lee ER, Frankl HD, Haile RW: Dietary intake of specific carotenoids and vitamins A, C, and E, and prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev5 :147– 153,1996 .
  • Shikany JM, Witte JS, Henning SM, Swendseid ME, Bird LC, Frankl HD, Lee ER, Haile RW: Plasma carotenoids and the prevalence of adenomatous polyps of the distal colon and rectum. Am J Epidemiol145 :662– 557,1997 .
  • Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman Jr JW: Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev5 :823– 833,1996 .
  • Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst87 :1767– 1776,1995 .
  • Schuurman AG, Goldbohm RA, Brants HA, van den Brandt PA: A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk. Cancer Causes Control13 :573– 582,2002 .
  • Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res59 :1225– 1230,1999 .
  • Nomura AMY, Stemmermann GN, Lee J, Craft NE: Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev6 :487– 491,1997 .
  • Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ: Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol157 :335– 344,2003 .
  • Cohen JH, Kristal AR, Stanford JL: Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst92 :61– 68,2000 .
  • Lu QY, Hung JC, Heber D, Go VLW, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, Zhang ZF: Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev10 :749– 756,2001 .
  • Hall AK: Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cells. Anticancer Drugs7 :312– 320,1996 .
  • Franceschi S, Bidoli E, Negri E, Zambon P, Talamini R, Ruol A, Parpinel M, Levi F, Simonato L, La Vecchia C: Role of micronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus. Int J Cancer86 :626– 631,2000 .
  • Zhang ZF, Kurtz RC, Yu GP, Sun M, Gargon N, Karpeh Jr M, Fein JS, Harlap S: Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer27 :298– 309,1997 .
  • Olmedilla B, Granado F, Blanco I, Rojas-Hidalgo E: Evaluation of retinol, alpha-tocopherol, and carotenoids in serum of men with cancer of the larynx before and after commercial enteral formula feeding. J Parenter Enteral Nutr20 :145– 149,1996 .
  • Zheng W, Blot WJ, Diamond EL, Norkus EP, Spate V, Morris JS, Comstock GW: Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Res53 :795– 798,1993 .
  • Nomura AM, Ziegler RG, Stemmermann GN, Chyou PH, Craft N: Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev6 :407– 412,1997 .
  • Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lipman SM, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK: Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev6 :687– 692,1997 .
  • Bidoli E, La Vecchia C, Talamini R, Negri E, Parpinel M, Conti E, Montella M, Carbone MA, Franceschi S: Micronutrients and ovarian cancer: a case-control study in Italy. Ann Oncol12 :1589– 1593,2001 .
  • Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willett WC, Stampfer MJ, Egan KM: A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control12 :83– 90,2001 .
  • McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S: Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control11 :965– 974,2000 .
  • Jain MG, Rohan TE, Howe GR, Miller AB: A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol16 :889– 905,2000 .
  • Kucuk O, Churley M, Goodman MT, Franke A, Custer L, Wilkens LR, St. Pyrek J: Increased plasma level of cholesterol-5β,6β-epoxide in endometrial cancer patients. Cancer Epidemiol Biomarkers Prev3 :571– 574,1994 .
  • Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu M: Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer77 :211– 216,1998 .
  • O’Connor I, O’Brien N: Modulation of UVA light-induced oxidative stress by β-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci16 :226– 230,1998 .
  • Nomura AM, Lee J, Stemmermann GN, Franke AA: Serum vitamins and the subsequent risk of bladder cancer. J Urol170 :1146– 1150,2003 .
  • Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci E: Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst91 :605– 613,1999 .
  • Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D: Intake of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer87 :960– 965,2002 .
  • Zeegers MP, Goldbohm RA, van den Brandt P: Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands cohort Study. Br J Cancer85 :977– 983,2001 .
  • Garcia R, Gonzalez CA, Agudo A, Riboli E: High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer35 :212– 214,1999 .
  • Botterweck AA, van den Brandt PA, Goldbohm RA: Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer88 :737– 748,2000 .
  • Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E: Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control10 :71– 75,1999 .
  • Tsubono Y, Tsugane S, Gey KF: Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer34 :56– 61,1999 .
  • Abneth CC, Qiao YL, Dawsey SM, Buckman DW, Yang CS, Blot WJ, Dong ZW, Taylor PR, Mark SD: Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China. Cancer Causes Control14 :645– 655,2003 .
  • Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW: Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev2 :335– 339,1993 .
  • Potischman N, Herrero R, Brinton LA, Reeves WC, Stacewicz-Sapuntzakis M, Jones CJ, Brenes MM, Tenorio F, de Britton RC, Gaitan E: A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators. Am J Epidemiol134 :1347– 1355,1991 .
  • Goodman MT, Kiviat N, McDuffie K, Hankin JH, Hernandez B, Wilkens LR, Franke A, Kuypers J, Kolonel LN, Nakamura J, Ing G, Branch B, Bertram CC, Kamemoto L, Sharma S, Killeen J: The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev7 :537– 544,1998 .
  • Nagata C, Shimizu H, Yoshikawa H, Noda K, Nozawa S, Yajima A, Sekiya S, Sugimori H, Hirai Y, Kanazawa K, Sugase M, Kawana T: Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan. Br J Cancer81 :1234– 1237,1999 .
  • VanEenwyk J, Davis FG, Bowen PE: Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer48 :34– 38,1991 .
  • Schiff MA, Patterson RE, Baumgartner RN, Masuk M, van Asselt-King L, Wheeler CM, Becker TM: Serum carotenoids and risk of cervical intraepithelial neoplasia in southwestern American Indian women. Cancer Epidemiol Biomarkers Prev10 :1219– 1222,2001 .
  • Peng YM, Peng YS, Childers JM, Hatch KD, Roe DJ, Lin Y, Lin P: Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer Epidemiol Biomarkers Prev7 :347– 350,1998 .
  • Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K: Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev6 :917– 923,1997 .
  • Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL: Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV Natural History Study. J Infect Dis188 :1508– 1516,2003 .
  • Gonzalez S, Astner S, An W, Goukassian D, Pathak MA: Dietary lutein/zeaxanthin decreased ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice. J Invest Dermatol121 :399– 405,2003 .
  • Fung TT, Spiegelman D, Egan KM, Giovannucci E, Hunter DJ, Willett WC: Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer103 :110– 115,2003 .
  • Wingerath T, Sies H, Stahl W: Xanthophyll esters in human skin. Arch Biochem Biophys355 :271– 274,1998 .
  • Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X, Drake T, Merz NB, Fogelman AM: Oxygenated carotenoid lutein and progression of early atherosclerosis. The Los Angeles Atherosclerosis Study. Circulation103 :2922– 2927,2001 .
  • Panasenko OM, Sharov VS, Briviba K, Sies H: Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch Biochem Biophys373 :302– 305,2000 .
  • Rowley K, Walker KZ, Cohen J, Jenkins AJ, O’Neal D, Su Q, Best JD, O’Dea K: Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust178 :495– 500,2003 .
  • Boosalis MG, Snowdon DA, Tully CL, Gross MD: Acute phase response and plasma carotenoid concentrations in older women: findings from the Nun Study. Nutrition12 :475– 478,1996 .
  • Dwyer JH, Paul-Labrador MJ, Fan J, Shircore AM, Merz CNB, Dwyer KM: Progression of carotid intima-media thickness and plasma antioxidants: The Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol24 :313– 319,2004 .
  • Iribarren C, Folsom AR, Jacobs Jr DR, Gross MD, Belcher JD, Eckfeldt JH, for the ARIC Study Investigators: Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. Arterioscler Thromb Vasc Biol17 :1171– 1177,1997 .
  • Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ: Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation90 :1154– 1161,1994 .
  • Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC: Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr77 :1390– 1399,2003 .
  • Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Ma J: Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation108 :802– 807,2003 .
  • Sesso HD, Buring JE, Norkus EP, Gaziano JM: Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr79 :47– 53,2004 .
  • D’Odorico A, Martines D, Kiechl S, Egger G, Oberhollenzer F, Bonvicini P, Sturniolo GC, Naccarato R, Willeit J: High plasma levels of α- and β-carotene are associated with a lower risk of atherosclerosis. Results from the Bruneck study. Atherosclerosis153 :231– 239,2000 .
  • Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JCM: Serum carotenoids and atherosclerosis. The Rotterdam Study. Atherosclerosis148 :49– 56,2000 .
  • Ruiz Rejon F, Martin-Pena G, Granado F, Ruiz-Galiana J, Blanco I, Olmedilla B: Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. Nutrition18 :26– 31,2002 .
  • Polidori MC, Savino K, Alunni G, Freddio M, Senin U, Sies H, Stahl W, Mecocci P: Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. Free Radic Biol Med32 :148– 152,2002 .
  • Wright AJA, Southon S, Chopra M, Meyer-Wenger A, Moser U, Granado F, Olmedilla B, Corridan B, Hinninger I, Roussel AM, van den Berg H, Thurnham DI: Comparison of LDL fatty acid and carotenoid concentrations and oxidative resistance to LDL in volunteers from countries with different rates of cardiovascular disease. Brit J Nutr87 :21– 29,2002 .
  • Hininger IA, Meyer-Wenger A, Moser U, Wright A, Southon S, Thurnham D, Chopra M, van den Berg H, Olmedilla B, Favier AE, Roussel AM: No significant effects of lutein, lycopene or β-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr20 :232– 238,2001 .
  • Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC: Relation of consumption of vitamin E, vitamin C and carotenoids to risk for stroke among men in the United States. Ann Intern Med130 :963– 970,1999 .
  • Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P: Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke31 :2301– 2306,2000 .
  • Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P: Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res36 :265– 268,2002 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.